Juan Antonio Virizuela Echaburu
JUAN ANTONIO VIRIZUELA ECHABURUJUAN ANTONIO VIRIZUELA ECHABURU

Juan Antonio Virizuela Echaburu

MEDICAL ONCOLOGY SPECIALIST
Oncología Médicaen/specialities/oncologia-medica

CV Médicos biobuilder con centros Juan Antonio Virizuela Echaburu

Centros en los que trabaja el profesional

See more specialists on Sevillasevilla

en/medical-staff/oncologist

Key information

  • Corresponding Academic
    2014
  • Latest Publication:
    Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
  • Belongs to:
    Sociedad Española de Oncología Médica

Professional Details

Hospital Quirónsalud Sagrado Corazón
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
May 2023 - Present
Hospital Quirónsalud Infanta Luisa
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
May 2023 - Present
Hospital Quironsalud Sagrado Corazón
Head of service
January 2005 - January 2016
Hospital Universitario Virgen Macarena
Specialist doctor
January 2002 - January 2016
Instituto Oncológico Teknon
Assistant Director
January 2001 - Present
Hospital Gral. de Llerena
Director of the Oncology Unit
January 1997 - January 2000
Hospital Universitario Juan Ramón Jiménez
Specialist doctor
January 1989 - January 1997
Centro Regional de Oncología de Sevilla
Specialist doctor
January 1985 - January 1989
Instituto Oncológico Teknon Barcelona
Assistant Director
Hospital de Bermeo
Coordinator of the Oncology Service
Free University Hospital Amsterdam
Stay
Memorial Sloan Ketterin Cancer Center
Stay
MD Anderson de Houston
Stay
Hospital de Bermeo
Coordinator of the Oncology Service
Study
Doctor of Medicine
Specialized Healthcare Training
Specialist in Medical Oncology
Another qualification
Master's Degree in Hospital Management
university
Another qualification
University Expert in Health Sciences Research: Quantitative and Qualitative Methodologies
university
Another qualification
Master's Degree in Genetic Counseling
Another qualification
Senior Management Program in Healthcare Institutions
university
Another qualification
European Title in Medical Oncology
Another qualification
Postgraduate Degree in Immuno-oncology
university
Another qualification
Master's degree in Health Sciences research: quantitative and qualitative methodologies
Another qualification
Stay at Free University Hospital Amsterdam
Another qualification
Stay at MD Anderson in Houston
Another qualification
Master's Degree in Genetic Counseling in Cancer
Another qualification
Stay at Memorial Sloan Kettering Cancer Center
Another qualification
Postgraduate degree in Immuno-Oncology
CLINICAL TUTOR
U.G.G DE ONCOLOGÍA INTEGRAL
January 2013 - January 2017
HONORARY ASSISTANT
DEPARTAMENTO DE ANATOMÍA Y EMBRIOLOGÍA HUMANA
January 2011 - January 2012
DEPARTMENT OF MEDICINE
MEDICAL ONCOLOGY
UNIVERSIDAD DE SEVILLA
January 2002 - January 2010
SOLTI-1303 - HQSCOR - . PATRICIA II: Phase II clinical trial of the combination of palbociclib, trastuzumab, and end-stage renal therapy...
SOLTI
SOLTI-2101 - HQSCOR - 2021-002027-38. Phase III, multicenter, open-label study of ribociclib compared to palbociclib in patients...
SOLTI
WO42133 - HQSCOR - 2020-001007-16. Multicenter, randomized, open-label, two-arm neoadjuvant treatment phase II study...
GEICAM (Spanish Breast Cancer Research Group Foundation)
Publicly funded projects
Public entities
FISS Projects
FISS
DS8201-A-U035 - HQSCOR - 2020-003982-20. Phase III, Multicenter, Randomized, Open-Label, Controlled Study of Trastuzumab Deruxtecán...
Daiichi Sankyo
SOLTI-1501 - HQSCOR - NCT02802748. Randomized, open-label, parallel cohort phase 0 trial of oral letrozolam/vinorelbine...
UC-0140/1812 - HQSCOR - 2018-003832-57. DOLAF: An International Phase II Multicenter Study of Durvalumab (MEDI4736) Plus OLAparib More...
UNICANCER
GEICAM/2014-12 - HQSCOR - 2015-002437-21. Phase II, multicenter, randomized, double-blind, parallel-group study to compare...
GEICAM (Spanish Breast Cancer Research Group Foundation)
Rare Care tumor European Project
European Union
AFT-05-ABCSG 42-BIG 14-03 - HQSCOR - 2014-005181-30. Randomized Phase III Study of Palbociclib with Adjuvant Endocrine Therapy vs. Mon...
Austrian Breast & Colorectal Cancer Group (ABCSG)
EORTC-1745-ETF-BCG (APPALACHES) - HQSCOR - 2018-002553-30. Phase II study of adjuvant therapy with palbociclib as an alternative to chemotherapy in pa...
European Organisation for Research and Treatment of Cancer (EORT)
D3615C00001 - HQSCOR - . Randomized, double-blind, phase III study to evaluate the efficacy and safety of capiva...
AstraZeneca
Privately funded project
Private entity
Multicenter clinical trials
private, public and European funding
RE05 - HQSCOR - 2006-006079-19. SORCE. Phase III, randomized, double-blind clinical trial comparing sorafenib with placebo...
Ramón Domínguez Foundation for Research, Development and Innovation
SOLTI-1716 - HQSCOR - 2018-003367-58. TATEN: Phase II clinical trial targeting non-luminal disease determined by the platform...
SOLTI
RLL-CAB-2011-01 - HQSCOR - 2011-001218-32. COMETA. Randomized phase II-b study of Cabazitaxel in metastatic colorectal cancer resistant to...
Ramón Domínguez Foundation for Research, Development and Innovation
D361EC00001 - HQSCOR - 2021-005201-27. Phase III, double-blind, randomized, placebo-controlled study to evaluate the efficacy...
AstraZeneca
AFT-38 - HQSCOR - 2017-000419-17. Phase III, randomized, open-label trial to evaluate the efficacy and safety of palbocycli...
Alliance Foundation Trials LLC
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Journal Article
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER).
Journal Article, Research Support, Non-U.S. Govt
Sociedad Española de Oncología Médica
Sociedad Española de Oncología Médica
HUV Macarena
Sociedad Española de Oncología Médica
HUV Macarena
Fundación Centro Regional de Calidad y Acreditación Sanitaria de Castilla y León
SEOM
SEOM
Corresponding Academic
REAL ACADEMIA DE MEDICINA DE SEVILLA
Make an appointment with this professional

Consulta el contenido multimedia de este profesional.

Hospitals

Book an appointment now at one of our hospitals.

Articles on

Browse the latest articles on Tu canal de salud.

Últimas colaboraciones en tucanaldesalud.com Juan Antonio Virizuela Echaburu

Artículos, entrevistas o vídeos en los que ha colaborado

No tienes seguro de saludNo tienes seguro de salud

¿No tienes seguro de salud?

Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.